General hospital and personal-use devices associated with adverse incidents

VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Y74 Cause of death: ICD-10 — Y74 2 out of 7 registries used, show all original rules.	56
4. Check minimum number of events None	56
5. Include endpoints None	56
6. Filter based on genotype QC (FinnGen only)	55

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Y7|Y8[0-2]

NAME	VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Y74
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Y74
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to General hospital and personal-use devices associated with adverse incidents based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	55	26	29
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	49.67	43.23	55.44

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
56: Matched controls
560

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Y74

ICD-10 Finland

General hospital and personal-use devices associated with adverse incidents

+∞

57.6

ZXE00

NOMESCO Finland

One hour or less

7.3

11.6

143

R4110

NOMESCO Finland

Physiotherapy

6.3

10.9

ZXD10

NOMESCO Finland

Scheduled procedure

5.7

9.4

135

Z2221

NOMESCO Finland

Medical doctor

5.5

9.2

ZXE10

NOMESCO Finland

More than one and less than three hours

4.5

7.3

120

ZXD05

NOMESCO Finland

Urgent procedure

4.5

7.1

122

Z3231

NOMESCO Finland

Registered nurse

4.4

6.7

Y74.8

ICD-10 Finland

General hospital and personal-use devices associated with adverse incidents, miscellaneous devices, not elsewhere classified

+∞

6.4

R03BB04

ATC

tiotropium bromide; inhalant

7.7

6.2

N02AX02

ATC

tramadol; systemic, rectal

4.0

6.2

155

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4.46

6.17

4.0

2.4

0.62

1.06

e6/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4.44

5.96

4.1

2.4

1.25

3.07

e6/l

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4.01

4.24

2.4

3.3

4.36

18.47

umol/l

0.88

(3014576) Chloride [Moles/volume] in Serum or Plasma

3.81

3.97

3.6

8.9

104.50

103.91

mmol/l

0.23

(3049717) Cytology report of Urine Cyto stain

8.68

3.67

1.7

2.1

—

(36304419) Bacteria [Presence] in Urine

111

2.82

3.34

4.3

2.6

—

(3002582) Erythrocytes [#/volume] in Urine

121

2.72

3.19

4.1

2.7

56.20

569.37

e6/l

0.47

(3018095) Leukocytes [#/volume] in Urine

145

2.66

3.16

4.9

3.3

88.34

91.36

e6/l

0.02

101

(3030467) Casts [#/volume] in Urine by Automated count

115

2.70

3.09

4.3

2.6

0.15

0.31

e6/l

0.54

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.69

2.64

4.7

3.7

14.33

33.60

ng/l

0.73

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

2.63

0.0

4.8

—

32.71

—

(3052851) Hemolysis interference index of Serum or Plasma

5.45

2.47

4.0

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.54

2.44

1.9

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.78

2.33

1.2

1.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

148

2.24

2.21

4.2

2.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

5.36

2.11

1.2

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.26

1.95

3.3

2.9

—

(3021589) Normoblasts [#/volume] in Blood

173

2.08

1.89

7.1

8.3

0.00

e9/l

0.50

138

(3013650) Neutrophils [#/volume] in Blood by Automated count

238

2.09

1.88

9.5

7.8

3.88

4.17

e9/l

0.39

208

(3013512) EKG study

129

0.33

1.79

2.8

4.5

—

(3000492) Spirometry study

2.82

1.77

1.6

1.1

—

(3001604) Monocytes [#/volume] in Blood

196

1.99

1.72

6.7

4.5

0.54

0.60

e9/l

0.53

171

(3013115) Eosinophils [#/volume] in Blood

206

1.98

1.69

6.9

4.9

0.20

0.17

e9/l

0.37

181

(3006315) Basophils [#/volume] in Blood

197

1.98

1.68

6.7

4.5

0.05

0.04

e9/l

1.05

172

(36660697) Celiac disease serology panel - Serum

2.74

1.67

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

189

1.96

1.65

4.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

172

1.96

1.61

5.7

35.47

35.59

g/l

0.04

164

(3023368) Bacteria identified in Blood by Culture

115

1.99

1.50

5.5

4.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.48

1.48

1.9

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

204

1.87

1.46

6.7

4.7

1.69

2.02

e9/l

0.53

182

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.42

1.45

1.9

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.61

1.44

1.3

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.79

1.41

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.12

1.39

3.6

42.4

—

(21494755) Public health laboratory ask at order entry panel

2.24

1.34

1.0

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.56

1.28

3.2

6.1

24.73

24.52

mmol/l

—

(3000991) Gas panel - Venous blood

2.35

1.13

3.6

11.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

180

1.70

1.09

2.2

2.0

94.43

96.15

pmol/l

0.09

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.21

1.07

1.1

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.04

1.07

1.8

1.6

—

(40768797) Stomach Pathology biopsy report

1.96

1.03

1.5

1.3

—

(3000494) Fungus identified in Specimen by Culture

1.95

1.03

1.1

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

0.00

1.00

0.0

3.8

—

0.79

—

(1761868) Lipid panel - Serum or Plasma

163

0.53

0.99

2.3

2.7

—

(3003694) ABO and Rh group [Type] in Blood

122

1.70

0.96

1.8

1.5

—

(40758558) Short blood count panel - Blood

108

1.67

0.86

7.2

6.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.76

0.83

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1.87

0.81

2.3

2.7

—

(3002256) Pathology report gross observation

1.83

0.80

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.76

0.78

1.9

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

111

1.62

0.77

2.9

2.8

—

(4034850) Laboratory test

0.00

0.61

0.0

17.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.61

0.0

4.3

—

55.03

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.61

0.0

1.4

—

(3022313) Gas panel - Capillary blood

0.00

0.60

0.0

4.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

100

1.53

0.59

2.6

2.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1.61

0.59

1.4

1.2

—

54.72

—

(3026782) Osmolality of Urine

1.52

0.52

1.8

2.5

564.14

538.32

mosm/kgh2o

—

(3024731) MCV [Entitic volume]

492

0.64

0.51

28.7

19.8

90.77

90.93

0.09

483

(3000963) Hemoglobin [Mass/volume] in Blood

492

0.64

0.51

28.9

20.0

133.26

136.82

g/l

1.13

483

(3009542) Hematocrit [Volume Fraction] of Blood

492

0.64

0.51

28.6

19.9

40.10

40.37

0.18

466

(3007461) Platelets [#/volume] in Blood

492

0.64

0.51

28.6

19.8

260.57

244.89

e9/l

1.03

478

(3035941) MCH [Entitic mass]

491

0.65

0.48

28.6

19.8

30.07

30.41

0.73

482

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

428

0.71

0.48

4.4

4.8

5.81

5.90

mmol/l

0.20

390

(3044640) Blood type and Crossmatch panel - Blood

143

1.38

0.44

3.3

2.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.41

0.43

4.3

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.42

0.0

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.42

0.0

2.9

—

(3012544) pH of Venous blood

1.52

0.41

1.2

6.1

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.41

0.0

2.8

—

0.12

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

202

1.33

0.41

3.3

2.7

144.86

101.38

ug/l

0.35

187

(3026008) Bacteria identified in Urine by Culture

127

1.36

0.39

3.6

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.61

0.39

2.4

1.4

—

(4035726) Immunohistochemistry procedure

1.48

0.37

1.8

1.2

—

(3003396) Base excess in Arterial blood by calculation

1.37

0.35

5.0

19.0

0.73

1.46

mmol/l

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

120

1.34

0.35

3.5

3.1

47.40

55.17

u/l

0.49

112

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

162

0.74

0.34

2.6

3.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

207

1.28

0.33

3.3

3.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

188

1.28

0.32

4.5

9.2

1.23

1.21

mmol/l

0.46

172

(3041096) Erythrocytes [Presence] in Urine by Automated

119

0.71

0.31

1.4

2.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

291

1.23

0.26

3.0

—

(3044889) 12 lead EKG panel

293

1.22

0.23

4.4

3.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.21

0.22

1.4

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

2.1

—

96.58

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

4.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.21

0.0

4.1

—

25.00

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(1616796) Gas panel - Central venous blood

0.00

0.21

0.0

2.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.21

0.0

2.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.20

0.0

2.3

—

3.92

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.15

0.18

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.17

0.17

3.5

2.5

2.21

2.32

g/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.74

0.17

2.8

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

299

1.16

0.16

3.7

3.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

123

1.18

0.14

4.4

4.5

17.56

23.63

—

(40768804) Tissue Pathology biopsy report

174

1.14

0.11

1.7

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.09

0.08

5.9

2.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.05

0.08

3.8

2.6

12.46

14.64

umol/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

418

1.12

0.07

18.8

11.7

86.86

82.65

ml/min/173m2

0.47

336

(3022217) INR in Platelet poor plasma by Coagulation assay

210

1.08

0.04

18.7

14.2

1.33

1.20

inr

—

(40761511) CBC panel - Blood by Automated count

466

0.93

0.01

12.6

12.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

445

0.95

0.00

19.9

13.2

21.12

22.57

mg/l

0.14

353

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

0.0

1.8

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

6.7

—

1.42

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

6.7

—

7.95

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

191.80

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.0

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.7

—

165.33

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

0.85

—

(3012441) Differential panel - Pleural fluid

0.00

0.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

2.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

77.50

—

(3045424) Erythrocytes [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

0.00

-0.00

0.0

2.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

3.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

2.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

1.7

—

4.63

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

2.0

—

36.14

—

(3022145) Colonoscopy Study observation

1.02

-0.00

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

2.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

0.55

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.6

—

213.00

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.8

—

105.60

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

-0.00

0.0

1.7

—

55.57

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

1.6

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.96

-0.00

1.6

1.06

1.50

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

3.92

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.8

—

(3011412) CD3 cells [#/volume] in Blood

0.00

-0.00

0.0

1.4

—

1.48

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.8

—

3.98

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS – General hospital and personal-use devices associated with adverse incidents

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

General hospital and personal-use devices associated with adverse incidents

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for General hospital and personal-use devices associated with adverse incidents (VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints